Vergentan


Indications and Reactions:

Role Indications Reactions
Secondary
Bronchial Carcinoma 11.0%
Nausea 11.0%
Pain 8.0%
Chronic Lymphocytic Leukaemia 7.4%
Prophylaxis 7.4%
Hypertension 6.7%
Arthritis 5.5%
Prophylaxis Of Nausea And Vomiting 5.5%
Acute Myeloid Leukaemia 4.3%
Infection 4.3%
Pyrexia 4.3%
Colon Cancer 3.7%
Convulsion 3.7%
Antiemetic Supportive Care 2.5%
Fluid Replacement 2.5%
Hypothyroidism 2.5%
Mineral Supplementation 2.5%
Sleep Disorder 2.5%
Thrombosis Prophylaxis 2.5%
Vomiting 2.5%
Toxic Epidermal Necrolysis 46.7%
Sepsis 26.7%
Pulmonary Sepsis 13.3%
Peripheral Sensory Neuropathy 6.7%
Sensory Disturbance 6.7%
Concomitant
Drug Use For Unknown Indication 14.1%
Hypertension 11.3%
Product Used For Unknown Indication 9.1%
Prophylaxis Of Nausea And Vomiting 8.5%
Non-small Cell Lung Cancer 8.2%
Abdominal Pain 8.1%
Prophylaxis 7.7%
Nausea 5.9%
Diarrhoea 3.0%
Goitre 2.8%
Pyrexia 2.7%
Thrombosis Prophylaxis 2.6%
Chest Pain 2.5%
Breast Cancer 2.1%
Prophylaxis Against Gastrointestinal Ulcer 2.1%
Acute Myeloid Leukaemia 1.9%
Hypokalaemia 1.9%
Pharyngeal Cancer Stage Unspecified 1.9%
Pain 1.8%
Rectal Cancer 1.8%
Wound Infection 15.2%
Pyrexia 9.1%
Vomiting 8.1%
Subileus 7.1%
Death 6.1%
Intestinal Obstruction 6.1%
Renal Infarct 5.1%
Malignant Neoplasm Progression 4.0%
Neutropenia 4.0%
Peritonitis 4.0%
Renal Failure Acute 4.0%
Acute Myocardial Infarction 3.0%
Bronchitis 3.0%
Coronary Artery Disease 3.0%
Coronary Artery Stenosis 3.0%
Infection 3.0%
Large Granular Lymphocytosis 3.0%
Pneumonia 3.0%
Pulmonary Embolism 3.0%
Rash 3.0%

Drug Data